Ten years ago, we have identified the selective two-pore domain potassium channel TREK-1 (TWIK-related potassium channel-1) as a potential target for depression treatment (Heurteaux et al., 2006; Borsotto et al., 2015). Here, KCNK2 is linked to depressive symptom measurement.